Global Hemodynamic Monitoring Systems Market
Hemodynamic Monitoring Systems Market: Hemodynamic monitoring is a procedure for measuring blood pressure inside heart, arteries, veins and also used for measuring levels of oxygen in the blood and blood flow. It enables to check the efficiency of a cardiovascular system. Hemodynamic monitoring is a mainspring for the care of a patient who is hemodynamically unstable and requires multiple approaches in both disease and context specific. A primary goal of hemodynamic monitoring is alerting the physicians about the forthcoming cardiovascular emergency. Generally, during high risk of surgery, it is used in this manner in an operating room. The other goal of hemodynamic monitoring is to attain specific information regarding disease processes in order to facilitate treatment. Hemodynamic monitoring effectiveness depends upon both abilities of diagnosis and technology availability.
Advanced technologies in non-invasive and minimally invasive techniques of hemodynamic monitoring will drive the market growth of hemodynamic monitoring systems. Rising prevalence of hypertension, obesity, diabetes which leads to cardiac diseases is also driving market growth. According to WHO reports, in 2012, globally about 17.5 Mn deaths are recorded because of cardiovascular diseases. Growing geriatric population along with rising in investments allocating for the geriatric will drive the growth of Hemodynamic Monitoring Systems Market. Availability of reimbursement policies in the industrialized economies will boost haemodynamic monitoring market growth. However, growing incidence of adverse reactions associated along with haemodynamic monitoring systems, strict FDA regulations for new systems approval and the fact that precision of carbon dioxide determination is adversely affected under low flow conditions are the few factors that are hindering the Hemodynamic Monitoring Systems Market growth.
The global Hemodynamic Monitoring Systems Market is classified on the basis of Product, type, technique end user, and geography.
Based on product, the Market is segmented into the following
- Haemodynamic Monitoring Systems
Based on types, the Market is segmented into the following
- Non invasive
- Minimally invasive
Based on end user, the Market is segmented into the following
- Diagnostic centres
- Catheterization laboratories
Growing initiatives taken by the government in order to increase awareness regarding respiratory and cardiovascular diseases will drive the market growth. For example, a government of India developed NPDCS (National Programme for Prevention and Control of Diabetes, Cardiovascular diseases, and Stroke) with a moto of improving public health. Programs like European Heart Health Charter which was developed by European society of cardiology in association with European heart network in order to increase awareness on cardiac diseases. Initiatives, like European platform for health, physical activity and diet are undertaken by European government for the promotion of good health and to decrease the lifestyle diseases.
On the basis of Geographical regions, hemodynamic monitoring systems market is classified as into five key regions as Europe, Asia- Pacific, North America, Europe, Middle East & Africa and Latin America. North American holds leading position in haemodynamic monitoring market due to increase in the patient pool of cardiovascular and cancer diseases. As per American Heart Association, in 2015, over 69.0% of the population is suffering from cardiac arrest and around 77.0% of the population are suffering from strokes.
Asia Pacific is expected to witness significant growth due to increasing prevalence of cardiovascular disease, growing technological advancements, rapid growth in the economy and favourable initiatives by the government. .Latin America is expected to show considerable growth due to lifestyles changes and increasing prevalence of cardiovascular disease. According to World heart federation, Latin America holds the high risk of abdominal obesity, high blood cholesterol, hypertension etc. In 2015, According to the study, about 1.6Mn deaths are recording in Latin America and the Caribbean because of cardiovascular diseases. The universal healthcare scheme in Brazil along with rising government focus for ameliorating public health should fuel the market growth. Players are focussing on the major collaborations, mergers and acquisitions in order to enhance their market share. For example, in 2016, LiDCO and Edwards Lifesciences Corporation entered into a strategic collaboration.
Some prominent players in the global hemodynamic monitoring systems market are LiDCO Group plc (U.K.), PULSION Medical Systems SE (Germany), Deltex Medical Group Plc. (U.K.), Cheetah Medical Inc. (Israel), Hemo Sapiens Inc. (U.S.), Osypka Medical GmbH (Germany), ICU Medical, Inc. (U.S.), Tensys Medical, Inc. (U.S.). Edwards Life sciences Corporation (U.S.) and Schwarzer Cardiotek GmbH (Germany).
- In June 2017, LiDCO received 510k clearance from U.S.FDA FOR its new advanced hemodynamic monitoring platform LiDCOunity.
- In April 2017, Edwards Life sciences Corporation, received FDA clearance for HemoSphere advanced monitoring platform used to provide clarity on hemodynamics of the patient.
- In May 2015, Cheetah Medical received U.S.FDA clearance and CE-mark approval from Europe for it’s a non-invasive hemodynamic monitoring system Starling SV.
- The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments, and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario